USD 0.0
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2005 | 1 Million USD | -78.68% |
2004 | 4.71 Million USD | 672.55% |
2003 | 610.44 Thousand USD | -79.06% |
2002 | 2.91 Million USD | 23.97% |
2001 | 2.35 Million USD | 36.41% |
2000 | 1.72 Million USD | 83.13% |
1999 | 941.06 Thousand USD | -41.18% |
1998 | 1.6 Million USD | 14.29% |
1997 | 1.4 Million USD | 0.0% |
1996 | 1.4 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2006 Q1 | 2.52 Million USD | 151.62% |
2006 Q3 | 4.54 Million USD | 38.07% |
2006 Q2 | 3.29 Million USD | 30.21% |
2005 Q2 | 689.98 Thousand USD | -88.59% |
2005 Q4 | 1 Million USD | 3.16% |
2005 Q1 | 6.04 Million USD | 28.21% |
2005 FY | 1 Million USD | -78.68% |
2005 Q3 | 974.49 Thousand USD | 41.23% |
2004 Q4 | 4.71 Million USD | 22.63% |
2004 FY | 4.71 Million USD | 672.55% |
2004 Q1 | 1.56 Million USD | 156.95% |
2004 Q2 | 2.99 Million USD | 90.79% |
2004 Q3 | 3.84 Million USD | 28.51% |
2003 Q1 | 2.77 Million USD | -4.8% |
2003 Q2 | 631.8 Thousand USD | -77.23% |
2003 FY | 610.44 Thousand USD | -79.06% |
2003 Q4 | 610.44 Thousand USD | 0.35% |
2003 Q3 | 608.31 Thousand USD | -3.72% |
2002 FY | 2.91 Million USD | 23.97% |
2002 Q4 | 2.91 Million USD | 33.19% |
2002 Q3 | 2.18 Million USD | 81.27% |
2002 Q2 | 1.2 Million USD | -48.0% |
2002 Q1 | 2.32 Million USD | -1.25% |
2001 Q3 | 3.05 Million USD | 20.78% |
2001 Q4 | 2.35 Million USD | -23.05% |
2001 FY | 2.35 Million USD | 36.41% |
2001 Q1 | 1.86 Million USD | 8.5% |
2001 Q2 | 2.52 Million USD | 35.28% |
2000 FY | 1.72 Million USD | 83.13% |
2000 Q2 | 2.01 Million USD | -16.41% |
2000 Q4 | 1.72 Million USD | -8.03% |
2000 Q3 | 1.87 Million USD | -6.97% |
2000 Q1 | 2.4 Million USD | 156.08% |
1999 Q1 | 1.4 Million USD | -12.5% |
1999 Q2 | 1.1 Million USD | -21.43% |
1999 Q3 | 1 Million USD | -9.09% |
1999 Q4 | 941.06 Thousand USD | -5.89% |
1999 FY | 941.06 Thousand USD | -41.18% |
1998 Q3 | 1.7 Million USD | 0.0% |
1998 Q2 | 1.7 Million USD | 6.25% |
1998 Q1 | 1.6 Million USD | 14.29% |
1998 FY | 1.6 Million USD | 14.29% |
1998 Q4 | 1.6 Million USD | -5.88% |
1997 FY | 1.4 Million USD | 0.0% |
1997 Q3 | 1 Million USD | -44.44% |
1997 Q2 | 1.8 Million USD | 125.0% |
1997 Q4 | 1.4 Million USD | 40.0% |
1997 Q1 | 800 Thousand USD | -42.86% |
1996 Q4 | 1.4 Million USD | 40.0% |
1996 Q1 | 800 Thousand USD | 0.0% |
1996 FY | 1.4 Million USD | 0.0% |
1996 Q3 | 1 Million USD | 42.86% |
1996 Q2 | 700 Thousand USD | -12.5% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
American Medical Technologies Inc. | 2.34 Million USD | 57.218% |
Ansell Limited | 1.32 Billion USD | 99.924% |
Ansell Limited | 1.33 Billion USD | 99.925% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 126.33 Million USD | 99.204% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 943.17 Thousand USD | -6.587% |
Psykey, Inc. | 2.47 Million USD | 59.366% |
ConvaTec Group Plc | 2.01 Billion USD | 99.95% |
ConvaTec Group Plc | 2.02 Billion USD | 99.95% |
Encision Inc. | 1.98 Million USD | 49.329% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | 3.04 Million USD | 66.936% |
Innovative MedTech Inc. | 6.13 Million USD | 83.613% |
LifePoint, Inc. | 2.45 Million USD | 59.037% |
Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 90.126% |
Paradigm Medical Industries, Inc. | 3.4 Million USD | 70.432% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 3.04 Million USD | 66.934% |
Reflect Scientific, Inc. | 776.32 Thousand USD | -29.494% |
SmileDirectClub, Inc. | 982.26 Million USD | 99.898% |
Sector 10, Inc. | 9.84 Million USD | 89.789% |
Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 99.926% |
SheerVision, Inc. | 1.43 Million USD | 29.768% |
United Health Products, Inc. | 1.99 Million USD | 49.707% |
Wearable Health Solutions, Inc. | 3.8 Million USD | 73.547% |
Yubo International Biotech Limited | 2.91 Million USD | 65.5% |